Joseph Pinzone, M.D.
Medical Oncology Physician in Thousand Oaks, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,815 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Joseph Pinzone, M.D. reported a CMS MIPS final score of 87.2/100 - above the 83.1 national average - and filed 4,773 Medicare Part D claims in 2023.
- 87.2/100
- MIPS score · +4 vs avg
- 5K
- Part D claims, 2023
- 51%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Joseph Pinzone, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
87 Top 46% higher than 54% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Joseph Pinzone, M.D. sits
This provider among medical oncology physician peers
Across the 1,527 medical oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Joseph Pinzone, M.D. writes more Part D claims than 100% of them and scores higher on MIPS quality than 55% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one medical oncology physician peer from a representative sample of 60; the gold marker is Joseph Pinzone, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Joseph Pinzone, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Joseph Pinzone, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in California
How Medical Oncology Physician compares to other specialties among California providers
Medical Oncology Physician ranks #177 among California's specialties (0% of in-state providers)
Each bar is a specialty's share of the California provider total, by primary NUCC taxonomy. The highlighted bar is Medical Oncology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Joseph Pinzone, M.D.'s 2023 MIPS final score plotted against the Medical Oncology Physician national average
- MIPS Final Score
- 87.2/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Medical Oncology Physician) - 87.2/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Medical Oncology Physician US NPIs
87.2/100 MIPS final score - 4.1 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Medical Oncology Physician. Quality dim: 84.1. Cost dim: 56.5.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Joseph Pinzone, M.D. appears in the CMS NPPES registry as a Medical Oncology Physician provider holding M.D. credentials at 125 W THOUSAND OAKS BLVD STE 300, Thousand Oaks, CA, 91360, with a listed phone of (805) 418-9100. NPI 1700893815 was issued on 08/02/2006.
Medicare Part D records for calendar year 2023 show 4,773 prescription claims written by this provider, covering 409 Medicare beneficiaries and totaling roughly $2.5 million in drug spend, split 44% brand-name and 51% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 87.2/100 for the 2023 performance year (Quality 84.1, Cost 56.5), compared with the national average of 83.1.
Medical Oncology Physician is a narrow specialty nationwide, with 3,815 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1700893815 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 08/02/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Joseph Pinzone, M.D.'s current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1700893815 is the unique 10-digit identifier CMS uses to link Pinzone across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Joseph Pinzone, M.D.. To verify Joseph Pinzone, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
44% brand-name claims vs 51% generic, on 4,773 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 8,743
- Total Day Supply
- 260,023
- Brand vs Generic
- 44% brand / 51% generic
- Brand Drug Cost
- $2.3M
- Generic Drug Cost
- $160K
Patient Demographics
- Average Patient Age
- 69.3 years
- Avg HCC Risk Score
- 1.57
- Gender Split
- 67% female / 33% male
- Age Distribution
- <65: 79, 65-74: 212, 75-84: 93, 85+: 25
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Joseph Pinzone, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
567 claims
- Metformin Hcl
Metformin Hcl
468 claims
- Jardiance
Jardiance
363 claims
- Januvia
Januvia
300 claims
- Atorvastatin Calcium
Atorvastatin Calcium
299 claims
- Pioglitazone Hcl
Pioglitazone Hcl
285 claims
- Trulicity
Trulicity
232 claims
- Alendronate Sodium 193
Alendronate Sodium
193 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 567 |
| Metformin Hcl | 468 |
| Jardiance Empagliflozin | 363 |
| Januvia Sitagliptin Phosphate | 300 |
| Atorvastatin Calcium | 299 |
| Pioglitazone Hcl | 285 |
| Trulicity Dulaglutide | 232 |
| Alendronate Sodium | 193 |
| Rosuvastatin Calcium | 147 |
| Ozempic Semaglutide | 94 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Joseph Pinzone, M.D. fits within the Medical Oncology Physician landscape nationally.
Joseph Pinzone, M.D.'s 4,773 claims are above the specialty average of 689.
Nearby Medical Oncology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Pinzone.
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Medical Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is Joseph Pinzone, M.D.'s specialty? ▼
How much does Joseph Pinzone, M.D. prescribe under Medicare Part D? ▼
What is Joseph Pinzone, M.D.'s Medicare quality score? ▼
Where is Joseph Pinzone, M.D. located? ▼
What is Joseph Pinzone, M.D.'s NPI number? ▼
Does Joseph Pinzone, M.D. prescribe more brand-name or generic drugs? ▼
How many Medical Oncology Physician providers are there in the US? ▼
What drugs does Joseph Pinzone, M.D. prescribe most often? ▼
Does Joseph Pinzone, M.D. accept Medicare? ▼
How can I verify Joseph Pinzone, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.